We previously utilized a genome-wide loss-of-function screen and found that reduced expression of B55α increased cellular sensitivity to CHKi's in non-small cell lung cancer (NSCLC) because of increased RS due to upregulation of oncogenic c-Myc expression 39. Here, PPP2R2A is linked to non-small cell lung carcinoma.